Table 1 Patient characteristics.

From: Retrospective evaluation of early thrombosis in transjugular intrahepatic portosystemic polytetrafluoroethylene-coated shunts under 2-day postinterventional heparinization

 

All (n = 94)

Study group (n = 54)

Add-on anticoagulation (n = 40)

p-value

Age, years

57.6 ± 10.9

58.2 ± 9.8

56.9 ± 12.3

n.s

Sex (male), n (%)

67 (71.3)

35 (64.8)

32 (80.0)

n.s

Indication *

   

n.s

Therapy refractory ascites

64

35

29

 

Gastrointestinal varices

40

18

22

 

Acute portal vein thrombosis (No flow on the main branch)

4

0

4

 

Others, e.g., Budd Chiari syndrome

6

1

5

 

TIPS location

   

n.s

Right hepatic vein to portal vein, n

75

44

31

 

Middle hepatic vein to portal vein, n

17

10

7

 

Left hepatic vein to portal vein, n

2

0

2

 

Preinterventional laboratory results

 Total bilirubin (mg/dl)

1.5 ± 1.1

1.6 ± 1.2

1.3 ± 0.8

n.s

 Serum creatinine (mg/dl)

1.2 ± 1.0

1.4 ± 1.3

1.0 ± 0.4

0.022

 Prothrombin time (s)

40.5 ± 8.1

41.1 ± 8.6

39.6 ± 7.3

n.s

INR

1.3 ± 0.2

1.4 ± 0.3

1.3 ± 0.2

n.s

Model for end-stage liver disease (MELD) score

13.7 ± 4.3

13.8 ± 4.6

11.3 ± 3.4

n.s

Preinterventional pressure gradient (mmHg)

15.3 ± 5.1

15.7 ± 5.1

14.7 ± 5.1

n.s

Postinterventional pressure gradient (mmHg)

6.9 ± 2.6

6.9 ± 2.1

7.1 ± 3.1

n.s

  1. * more than one possible; n.s., not significant.